Tharimmune completed a private sale of approximately $540 million to establish the Canton Coin treasury strategy.

CC-0,18%

Foresight News reports that the publicly traded company Tharimmune, Inc. has signed a private sale financing agreement with several institutions and accredited investors, planning to issue common stock at a price of $3.075 per share (or in the alternative of pre-financing warrants), with a total financing amount expected to be approximately $540 million, not including underwriting fees and other issuance costs. The financing is expected to be completed around November 6, 2025, subject to meeting customary closing conditions. The company plans to use the net proceeds from the financing to acquire Canton Coin (CC), which is used to support the interoperability and Settlement of the Canton network. Additionally, Tharimmune plans to operate additional validators on the Canton network as a Super Validator to earn more CC tokens. DRW and Liberty City Ventures are the main investors, with participants including ARK Invest, Bitwave, Broadridge, Clear Street, Copper, Digital Asset, Feynman Point Asset Management, Five North, Kaiko, Kenetic, Kraken, LendOS, Lukka, Nima Capital, MPCH, Obsidian Software, Polychain Capital, Proof Group, SBI Group, The Tie, Tradeweb Markets, and 7RIDGE. The Canton Foundation, as the regulatory body for the Canton network, is also participating in this transaction.

View Original
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.
Comment
0/400
No comments